Xbiom™ is a single platform that provides solutions to support clinical and non-clinical drug development across both R&D and regulatory submissions.
The Xbiom™ Platform is built on a common technology stack for big data and serves the emerging needs that are driven by standardization of study data, translational analysis and increased applications of pharmacogenomics. The platform provides common APIs and data services to integrate with other enterprise infrastructure.
Within the Xbiom platform there are four modules, as describe below, which can be deployed in a SaaS or on-premise configuration.
Xbiom™ is the big data platform for large pharma and biotechs with individual solutions tailored to both nonclinical and clinical industry needs in the areas of research and regulatory submission.
Regulatory – Clinical|
A solution for sponsors to collaboratively specify data requirements with their CROs and validate and package conformant data for regulatory compliant submissions to the FDA.
Insights – Clinical Biomarker|
A big data soution for integrating genomic and clinical biomarker data with bioinformatics registries to enable prosprective or retrospective cohort stratification.
Regulatory – Nonclinical|
A solution providing an end-to-end suite from collecting CRO and in-house study data through IND/NDA submission to the FDA. Including visualization and analytics capabilities.
Insights – Nonclinical|
A single research and discovery platform to support data-driven decisions through contextual aggregation of biomarkers signals and findings across all non-clinical study, species and drug candidates
PointCross Life Sciences Inc. delivers proven technology to support drug development through a suite of Nonclinical
and Clinical offerings
1291 E. Hillsdale Blvd, Suite 304
Foster City, California 94404 USA
Direct: +1 (650) 350 – 1900
Toll Free: +1 (844) 382 – 7257